AstraZeneca ‘very disappointed’ over axed £450m Liverpool vaccine project
by Julia Kollewe from World news | The Guardian on (#6V3B7)
As drugmaker reports 38% jump in profits, CEO denies tension with UK government after Speke plant decision
AstraZeneca's boss has broken its silence since ditching a 450m vaccine plant expansion in Liverpool a week ago, saying the drugmaker was very disappointed" to have been unable to make a business case for the investment.
Pascal Soriot told reporters on Thursday: This is one of those cases and we see that regularly, where we could not make the business case work ... and we needed a certain level of support to make this economically viable. And that was not possible for the government to justify, which we totally understand. On our side, we cannot justify this either. We were all very disappointed, but that's business life."
Continue reading...